Compare ADMA Biologics Inc (ADMA) vs Riot Platforms Inc (RIOT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs Riot Platforms Inc — how do they compare? ADMA Biologics Inc trades at $9.88 (market cap $2.22B), while Riot Platforms Inc trades at $20.86 (market cap $7.59B). The key difference: Riot Platforms Inc is far larger — about 3.4× ADMA Biologics Inc's market cap, and Riot Platforms Inc is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.
| ADMA | RIOT | |
|---|---|---|
Market Cap | $2.22B | $7.59B |
Sector | Health | Technology |
52-Week High | $20.38 | $28.67 |
52-Week Low | $7.60 | $11.33 |
Enterprise Value | $2.29B | $8.00B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ADMA trades at $9.83, up 0.82% today, with strong profitability metrics including a 32.98% net income margin and 41.9% ROE. Recent earnings show mixed results, with a beat in Q4 2025 but misses in Q1 and Q2 2026. Technical indicators are bullish overall, though RSI levels suggest overbought conditions. The stock faces significant legal headwinds from multiple securities fraud class actions filed in August 2026.
The outlook is cautiously optimistic given solid fundamentals and analyst support, but legal risks and recent earnings misses pose near-term challenges. Upside potential exists if the company can maintain profitability and resolve litigation, while downside risks include prolonged legal proceedings and execution missteps.
RIOT Platforms trades at $20.835, up 7.4% on news of a transformative $9.1 billion AI infrastructure deal with Anthropic. Despite bearish technical signals and consecutive quarterly losses, the stock shows strong momentum driven by the company's strategic pivot from bitcoin mining to data center operations. Analyst sentiment remains overwhelmingly positive with 94% buy ratings and a $33.40 consensus price target, representing significant upside potential.
The outlook hinges on successful execution of the AI infrastructure strategy, though substantial risks persist including negative cash flow, widening losses, and competitive pressures. Investors face a high-risk, high-reward scenario where the massive Anthropic deal could drive long-term value if operational challenges are overcome.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Riot Platforms Inc
Riot Platforms, Inc. is a Bitcoin mining company that focuses on building, operating, and expanding large-scale infrastructure for digital asset mining in North America. The company's operations include Bitcoin mining, data center hosting, and engineering solutions. Riot's strategy emphasizes vertical integration to maximize efficiency and scale its mining capacity, aiming to be a leader in the global Bitcoin and digital infrastructure industry.
Read more on RIOT →
